Is pharma still a bitter pill or is the worst over?

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

Published 5 years ago on Aug 08, 2016 1 minute Read

Nilesh Shetty, Associate fund manager, Quantum Asset Management: 

For the past five years, we didn’t own a single pharma stock as none was available at an attractive valuation. Today, the market is worried about the regulatory overhang facing the sector. As a result, most pharma stocks are trading lower and have underperformed the market. Some names are trading at 16-17x forward earnings as against 25x just a few months ago. At current


You don’t want to be left behind. Do you?

Our work is exclusively for discerning readers. To read our edgy stories and access our archives, you’ve to subscribe